-
Markets
-
Equities
Sustainable finance2025 Euronext ESG Trends ReportRead moreA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesRead moreThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETFs
The European market place for ETFsEuronext ETF EuropeRead moreInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Funds
-
Fixed Income
European Defence BondsGroupe BPCE lists the first bondRead moreFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Structured Products
-
Derivatives
Where European Government Bonds Meet the FutureFixed Income derivativesRead moreTrade mini bond futures on main European government bonds
-
Commodities
- Overview
- Quotes snapshot
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Delivery & settlement
- Specifications & arrangements
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesRead moreEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Resources
Designed to help students navigate the complexities of financial marketsEuronext Trading gameRead moreJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
Financial calendar
27 Jan 2025 08:41 CET
Financial calendar for Ultimovacs ASA
FINANCIAL YEAR 2024
27.03.2025 - Annual Report
24.04.2025 - Annual General Meeting
31.01.2025 - Quarterly Report - Q4
FINANCIAL YEAR 2025
21.08.2025 - Half-yearly Report
25.03.2026 - Annual Report
23.04.2026 - Annual General Meeting
08.05.2025 - Quarterly Report - Q1
06.11.2025 - Quarterly Report - Q3
12.02.2026 - Quarterly Report - Q4
Note that the fourth quarter webcast presentation has been rescheduled from
February 13 to January 31, 2025, due to the ongoing business combination with
Zelluna Immunotherapy AS, in order to fulfill regulatory requirements associated
with this process.
This information is published pursuant to the requirements set out in the
Continuing obligations.
More information:
Access the news on Oslo Bors NewsWeb site
Source
Ultimovacs ASA
Provider
Oslo Børs Newspoint
Company Name
ULTIMOVACS
ISIN
NO0010851603, NO0013524942
Symbol
ULTI
Market
Euronext Oslo Børs